Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
Orkin, C, DeJesus, E, Khanlou, H, Stoehr, A, Supparatpinyo, K, Lathouwers, E, Lefebvre, E, Opsomer, M, Van de Casteele, T, Tomaka, FVolume:
14
Language:
english
Journal:
HIV Medicine
DOI:
10.1111/j.1468-1293.2012.01060.x
Date:
January, 2013
File:
PDF, 303 KB
english, 2013